First-quarter net income of Hungarian pharmaceutical company Gedeon Richter fell 4% year-on-year to HUF 65.3 billion as operating profit stagnated and net financial gains narrowed, an earnings report published ahead of the opening bell on Tuesday shows. Revenue edged down 2% to HUF 220.2 billion, impacted by the continuing trend of the weaker dollar and […]
Hungarian nuclear medicine supplier Medi-Radiopharma is launching an R&D investment to develop a pioneering manufacturing technology, the Hungarian Investment Promotion Agency (HIPA) reports. Supported by the HIPA, the EUR 6.56 million investment aims to introduce an industry-scale, automated technology to produce radiopharmaceuticals, that is faster, and more efficient and accurate than the currently dominant manual, […]
GlaxoSmithKline Biologicals Ltd., based in Gödöllő, about 30 kilometers northeast of Budapest, serves as one of the world’s centers of excellence for vaccine manufacturing. The Gödöllő site has been producing vaccine components, bulk antigen and carrier protein since 2002, building on a 50-year scientific competence heritage in Hungary. The site produces the raw materials for […]
US-owned pharmaceutical company Viatris Komárom-Mylan Hungary will invest over EUR 16 million at its base in Komárom (northwest of Budapest), expanding packaging and quality control capacity. Mylan Hungary Ltd., part of the American Viatris group, is one of the key centers in the European packaging and quality control network. At its Komárom site, the company […]
Denmark-based Xellia Pharmaceuticals is investing EUR 70.85 million in Szigetszentmiklós, south of Budapest, further strengthening Hungary's role in the European healthcare and antibiotic supply chain. The development aims to create a modern, automated pharmaceutical manufacturing plant and promises create 91 new high value-added jobs. Headquartered in Copenhagen, Xellia Pharmaceuticals is a specialty pharmaceutical company focused […]
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the approval of Hungarian pharmaceutical company Gedeon Richter's drug FYLREVY as hormone replacement therapy for estrogen deficiency symptoms, Richter said on Friday. The European Commission will review the CHMP recommendation for a final decision […]
Egis Pharmaceuticals Ltd. has unveiled one of the most significant developments in its 112-year history in Budapest. The company will manufacture the active ingredient for a globally leading product at its new HUF 30 billion plant, which was financed from its own resources, the company told MTI on Thursday. According to the announcement, what makes […]
The biotechnology and pharmaceutical company Roche and the University of Szeged (SZTE) have agreed to support research, development, and educational activities and to implement joint innovation projects. The agreement was signed on Monday during the university's Innovation Day in the southeastern Hungarian city of Szeged. Judit Fendler, Chancellor of SZTE, said that in addition to […]
Net income of Hungarian pharmaceutical company Gedeon Richter fell 7% year-on-year to HUF 163.3bn in Q1-Q3, dropping on a financial loss, an earnings report posted ahead of the opening bell on Thursday shows. Revenue rose 7% to HUF 680.2 billion and operating profit climbed 8% to HUF 204.5 billion. A net financial loss of HUF […]
Pharmacenter Hungary has developed two oncology drugs in a HUF 535 million project, supported by a HUF 298m grant from the National Research, Development and Innovation Fund, the company said in a statement. The project started in October 2021 and was completed in September 2025. One of the resulting products is used in the therapy […]
Office space in Sanofi's international business service center has recently more than doubled in size, the French pharma giant announced this Thursday. Located in one of the Hungarian capital’s most dynamic business districts on Váci út, the Sanofi Budapest Hub has grown by 8,000 square meters to a total of 15,000, providing state-of-the-art workstations, community […]
Gedeon Richter Plc.'s performance in the first half of the year was in line with its annual plans, so it has not changed its expectations for this year, CEO Gábor Orbán said at a press conference following the flash report on Wednesday in Budapest. He said that, excluding exchange rate effects, they expect growth of […]
The Hungarian pharma company Gedeon Richter Plc.'s consolidated sales revenue for the first half of the year was HUF 465.5 billion, 10.9% higher than a year earlier, the company announced on the Budapest Stock Exchange (BÉT) website on Wednesday. Net profit for the first half of 2025 was HUF 120 billion, which is 13% lower […]
Switzerland-based pharmaceutical company Sandoz came to be an independent company in October 2023. For 20 years prior to that, it was the generic businesses division of Novartis. Now, Sandoz is a global leader in generic pharmaceuticals and biosimilars with the focus on bringing high quality medicines early to patients at affordable cost. The local subsidiary, […]
Hungary’s leading innovative pharmaceutical company, Novartis has been present in this country since the early nineties. The head of the local subsidiary, Novartis Hungary Ltd., Colette Matz tells Diplomacy&Trade about the company’s activities on the Hungarian market with special regard to the company’s contribution to Hungarian healthcare. The General Manager states that Novartis is proud […]
